ESC Premium Access

Do beta-blockers improve one-year survival in heart failure patients with atrial fibrillation? Results from the ESC-HF Registry

Congress Presentation

About the speaker

Associate Professor Krzysztof Ozieranski

Medical University of Warsaw, Warsaw (Poland)
0 follower

6 more presentations in this session

Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation in the PREFER in AF registry

Speaker: Associate Professor J. Siller-Matula (Vienna, AT)


Association between serum potassium and clinical outcomes in UK patients with heart failure

Speaker: Ms L. Qin (Gaithersburg, US)


Presence of micro- and macroalbuminuria and association with cardiac mechanics in type 2 diabetes

Speaker: Doctor P. Jorgensen (Hellerup, DK)


Empagliflozin reduces heart failure irrespective of control of blood pressure, low density lipoprotein cholesterol and HbA1c

Speaker: Doctor D. Fitchett (Toronto, CA)


Multi-ethnic comparisons of diabetes in heart failure with reduced ejection

Speaker: Doctor J. Yap (Singapore, SG)


Access the full session

Fresh look at heart failure

Speakers: Associate Professor K. Ozieranski, Associate Professor J. Siller-Matula, Ms L. Qin, Doctor P. Jorgensen, Doctor D. Fitchett...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb